MLR Status: Review Required|Claims must be source-backed before external use
Internal draft only. Medical, regulatory, and legal review required.
AI Operating System for Pharma Commercialization

From Molecule Discovery to Market-Dominating Brand Plan

Unify pharmacology, landmark PubMed trials, FDA/CDSCO labels, trademark vetting, epidemiological forecasting, and doctor visual aids in a single, audit-ready platform.

Quick Start Presets:

Active Pharma Brand Initiatives

Select a project to access its 16 integrated scientific and commercial modules

Loading brand initiativesin progress

Molecule to Market AI · Developed by Animesh Mishra

16 Integrated Commercialization Modules

Everything required to take a compound from pharmacological validation to final field force execution. Ten of the sixteen are shown here, in the order a plan is built.

1. Molecule Intelligence

Pharmacology, MoA, PK/PD (ADME), safety, and receptor pathways.

2. Research Evidence

PubMed trial extraction, sample size, hazard ratios, and claim backing.

3. Clinical Trials

Active pipeline radar, phase status, and competitor trials on CT.gov.

4. Regulatory Labels

DailyMed SPL and CDSCO labels with black-box alert tracking.

5. Trademark Studio

Phonetic Soundex collision analysis and pharma stem generation.

6. Competitors & SWOT

2x2 positioning quadrant, battlecards, and claim differentiation.

7. Market Forecasting

Epidemiological patient funnel and 3-scenario 5-year revenue modeling.

8. Brand Plan Builder

12-section Notion-style strategic canvas with live citation backing.

9. Creative & Detailing

Visual Aid 6-slide detailer flow, LBL brief, and MR objection simulator.

10. Report Center

1-click export to Word (.docx), PowerPoint (.pptx), and Excel (.xlsx).